Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare ...

Canada's legal cannabis market, valued at USD 3.25 Billion in 2024, is projected to reach USD 5.79 Billion by 2030, growing at a 12% CAGR. Key drivers include health benefits awareness, increasing ...

This was the stock's third consecutive day of losses.